Dose-dependent reduction in proliferation and viability of PaCa-2 and Huh7 tumor cell lines via lowering of mRNA METTL3 level.Its mechanism is associated with PI3K/Akt/mTOR, Wnt/b-catenin, and MAPK/ERK1/2 pathways. The gene discussed is MAPK3; the disease is neoplasm.